Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Furo[2,3-h] chromene compound and use for preventing platelet aggregation

A platelet aggregation and compound technology, applied in the field of medicine, can solve the problems of poor stability and low content of natural flavonoids, and achieve the effect of a simple synthesis method

Inactive Publication Date: 2009-07-22
SHENYANG PHARMA UNIVERSITY
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, the content of natural flavonoids is low, and the stability of 4-chromanone Mannich bases is poor. We modified the structures of flavonoids and 4-chromanones, designed and synthesized a series of furo[2,3- h] chromene compounds to overcome the above-mentioned shortcomings of natural flavonoids and 4-chromanones

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Furo[2,3-h] chromene compound and use for preventing platelet aggregation
  • Furo[2,3-h] chromene compound and use for preventing platelet aggregation
  • Furo[2,3-h] chromene compound and use for preventing platelet aggregation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1: 8-benzoyl-9-methylfuro[2,3-h]-4-chromanone

[0023] Mix 3mmol 7-hydroxy-8-acetyl-4-chromanone, 3mmol α-chloroacetophenone, 30mmol anhydrous potassium carbonate, 50mL dry acetone, and stir and reflux for 7 hours. After cooling, suction filtration, rotary evaporation to evaporate the acetone, 30 mL of ethyl acetate was added, followed by washing with 10 mL of water and 10 mL of saturated sodium chloride aqueous solution, drying, and rotary evaporation to remove ethyl acetate. Column chromatography separation (oil ether: ethyl acetate = 8:1) to obtain a white solid. The yield was 42%, MS m / z(M): 306.31. 1 H-NMR(d 6 -DMSO): δ 1.94 (3H, s), 2.97 (2H, t), 4.13 (2H, t), 7.06 (1H, d, J = 8.88 Hz), 7.45-7.54 (3H, m), 7.71 (1H , D, J = 8.91 Hz), 7.81 (2H, m).

Embodiment 2

[0024] Example 2: 8-(4-Methylbenzoyl)-9-methylfuro[2,3-h]-4-chromanone

[0025] According to the method of Example 1, reacted with 7-hydroxy-8-acetyl-4-chromanone and 4-methyl-α-chloroacetophenone to obtain a white solid with a yield of 38%. MS m / z(M): 320.34. 1 H-NMR(d 6 -DMSO): δ 1.95 (3H, s), 2.35 (3H, s), 2.97 (2H, t), 4.13 (2H, t), 7.06 (1H, d, J = 8.92 Hz), 7.25 (2H, dd) , J=1.80, 8.88 Hz), 7.69-7.71 (3H, m).

Embodiment 3

[0026] Example 3: 8-(4-Chlorobenzoyl)-9-methylfuro[2,3-h]-4-chromanone

[0027] According to the method of Example 1, reacted with 7-hydroxy-8-acetyl-4-chromanone and 4-chloro-α-chloroacetophenone to obtain a white solid with a yield of 32%. MS m / z(M): 340.76. 1 H-NMR(d 6 -DMSO): δ 1.94 (3H, s), 2.97 (2H, t), 4.13 (2H, t), 7.06 (1H, d, J = 8.91 Hz), 7.46 (2H, dd, J = 1.80, 8.88 Hz ), 7.71-7.75 (3H, m).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention pertains to the field of medical technology and relates to a furo [2, 3-h] chromene compound and an application thereof for inhibiting platelet aggregation; the furo [2, 3-h] chromene compound, pharmaceutically-acceptable salt, or stereo-isomers and pre-drugs of the furo [2, 3-h] chromene compound, as well as pharmaceutical compatibility acceptable carriers or diluents of the furo [2, 3-h] chromene compound can be used as platelet aggregation inhibitors. The structural formula of the furo [2, 3-h] chromene compound is as shown above, wherein, X can be chosen from CH2 or C=O, R1 can be independently chosen from H or a substituted or un-substituted aromatic base, R2 can be independently chosen from H or a substituted or un-substituted aromatic base, and R can be independently chosen from H, alkyl group with one to four carbon atoms, chlorine, bromine, fluorin, methoxyl, nitryl or hydroxyl. The furo [2, 3-h] chromene compound has simple synthetic method, adapts to industrialized production and is more stable compared with natural analogues. Shown by biological activity assay, the furo [2, 3-h] chromene compound has antithrombin activity and is a platelet aggregation inhibiting drug.

Description

Technical field [0001] The invention belongs to the technical field of medicine, and relates to furo[2,3-h]chromene compounds and their use in anti-platelet aggregation. Background technique [0002] Clinical studies have shown that common clinical cardiovascular and cerebrovascular diseases such as hypertension, diabetes, angina pectoris, myocardial infarction, cerebral infarction and cerebral hemorrhage are all related to changes in platelet function and abnormal hemorheology (Tianjin Medicine, 1992, 20 (11): 684). Therefore, preventing platelet aggregation is of great significance. [0003] Platelets are produced by the lysis of mature megakaryocytes in the bone marrow. The newly formed platelets are large in size, have the ability to synthesize proteins, have strong adhesion, are prone to aggregation and release reactions, and have hemostatic function. It is currently believed that the physiological activities of platelets mainly include adhesion, aggregation and release reac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D493/04A61K31/352A61P7/02A61P7/00A61P9/10A61P11/00A61P17/02A61P19/02A61P1/00A61P25/28A61P27/02A61P43/00
Inventor 胡春刘晓平洪秀云黄二芳王颖王世辉金丽萍宋爱华詹华强董婷霞
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com